Background : Clinical trials are most informative for evidence-based decision-making when they consistently measure and report outcomes of relevance to stakeholders, especially patients, clinicians, and policy makers. However, sometimes terminology used is interpreted differently by different stakeholders, which might lead to confusion during shared decision making. The construct dialysis adequacy is frequently used, suggesting it is an important outcome both for health care professionals as for patients. Objective : To assess the scope and consistency of the construct dialysis adequacy as reported in ran-domised controlled trials in hemodialysis, and evaluate whether these align to the insights and understanding of this construct by patie...
Abstract Background Chronic kidney disease is a signi...
AIM: To generate a consensus-based, prioritized list of core outcomes for trials in haemodialysis. ...
Introduction It is estimated that 25 000 people in the UK receive dialysis. Dialysis is an intrusive...
Background : Clinical trials are most informative for evidence-based decision-making when they consi...
BACKGROUND:Clinical trials are most informative for evidence-based decision-making when they consist...
BackgroundClinical trials are most informative for evidence-based decision-making when they consiste...
Background: Clinical trials are most informative for evidence-based decision making when they consis...
International audienceBACKGROUND: Clinical trials are most informative for evidence-based decision m...
Background: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
BACKGROUND: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
Objective:- the study amid to assess dialysis adequacy among hemodialysis patients with end-st...
INTRODUCTION Patients undergoing haemodialysis (HD) for end-stage kidney disease often report a p...
There is clear evidence of a link between dialysis adequacy (as measured by urea kinetic modeling or...
Objectives Patients undergoing haemodialysis report elevated symptoms and reduced health-related qua...
Introduction It is estimated that 25 000 people in the UK receive dialysis. Dialysis is an intrusive...
Abstract Background Chronic kidney disease is a signi...
AIM: To generate a consensus-based, prioritized list of core outcomes for trials in haemodialysis. ...
Introduction It is estimated that 25 000 people in the UK receive dialysis. Dialysis is an intrusive...
Background : Clinical trials are most informative for evidence-based decision-making when they consi...
BACKGROUND:Clinical trials are most informative for evidence-based decision-making when they consist...
BackgroundClinical trials are most informative for evidence-based decision-making when they consiste...
Background: Clinical trials are most informative for evidence-based decision making when they consis...
International audienceBACKGROUND: Clinical trials are most informative for evidence-based decision m...
Background: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
BACKGROUND: Chronic kidney disease is a significant contributor to mortality and morbidity worldwide...
Objective:- the study amid to assess dialysis adequacy among hemodialysis patients with end-st...
INTRODUCTION Patients undergoing haemodialysis (HD) for end-stage kidney disease often report a p...
There is clear evidence of a link between dialysis adequacy (as measured by urea kinetic modeling or...
Objectives Patients undergoing haemodialysis report elevated symptoms and reduced health-related qua...
Introduction It is estimated that 25 000 people in the UK receive dialysis. Dialysis is an intrusive...
Abstract Background Chronic kidney disease is a signi...
AIM: To generate a consensus-based, prioritized list of core outcomes for trials in haemodialysis. ...
Introduction It is estimated that 25 000 people in the UK receive dialysis. Dialysis is an intrusive...